Videos
Colorectal Cancer
Srdan Verstovsek, MD, PhD, discusses how to control symptoms while using hypomethylating agents in patients with myelofibrosis.
Thomas Powles, MD, shares his advice for community oncologists treating patients with bladder cancer in the frontline setting. According to Powles, this is a setting where there is a lot of uncertainty that can make decision making difficult.
Treatment Recommendations Upon Metastasis in CRPC
Optimal Management of Stage IIIA Hodgkin's Lymphoma
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ctDNA Refines Risk in Neoadjuvant-Resistant Breast Cancer
2
Promoting CAR T Access Focuses on Awareness, Capacity, and Economics
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Early AE Monitoring Is Key to Adjusting NALIRIFOX Dose in PDAC
5